Vimta Labs (NSE:VIMTALABS) Total Liabilities : ₹877 Mil (As of Mar. 2025)

View and export this data going back to 2005. Start your Free Trial

What is Vimta Labs Total Liabilities?

Vimta Labs's Total Liabilities for the quarter that ended in Mar. 2025 was ₹877 Mil.

Vimta Labs's quarterly Total Liabilities declined from Sep. 2024 (₹976.71 Mil) to Dec. 2024 (₹0.00 Mil) but then increased from Dec. 2024 (₹0.00 Mil) to Mar. 2025 (₹876.84 Mil).

Vimta Labs's annual Total Liabilities declined from Mar. 2023 (₹805.39 Mil) to Mar. 2024 (₹803.54 Mil) but then increased from Mar. 2024 (₹803.54 Mil) to Mar. 2025 (₹876.84 Mil).

Vimta Labs Total Liabilities Historical Data

The historical data trend for Vimta Labs's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimta Labs Total Liabilities Chart

Vimta Labs Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Total Liabilities

Get a 7-Day Free Trial

799.75

732.14

805.39

803.54

876.84

Vimta Labs Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															803.54	-	976.71	-	876.84

Vimta Labs Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Vimta Labs's Total Liabilities for the fiscal year that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	643.67	+	(32.24	+	200.93
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	877

Total Liabilities	=	Total Assets (A: Mar. 2025 )	-	Total Equity (A: Mar. 2025 )
	=	4665.32	-	3788.48
	=	877

Vimta Labs's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	643.67	+	(32.24	+	200.93
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	877

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	4665.32	-	3788.48
	=	877

Vimta Labs Total Liabilities Related Terms

Thank you for viewing the detailed overview of Vimta Labs's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Vimta Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimta Labs Ltd (NSE:VIMTALABS) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

524394:India

Address

Plot No.141/2 & 142, IDA, Phase-II, Cherlapally, R. R. District, Hyderabad, TG, IND, 500051

Website

https://www.vimta.com

Vimta Labs Ltd is a comprehensive contract research and testing organization, providing a wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and many other industries. Its services portfolio includes testing and contract research services in the fields of clinical research, pre-clinical research, clinical diagnostics, biopharma services, analytical testing, research and environmental studies, and Others. It has only one reportable segment namely Contract Research and Testing Services which generates the revenue.

Vimta Labs Headlines

No Headlines